IFP Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.48M | Buy |
51,925
+10,048
| +24% | +$286K | 0.04% | 447 |
|
2025
Q1 | $1.01M | Sell |
41,877
-247
| -0.6% | -$5.97K | 0.03% | 547 |
|
2024
Q4 | $1.7M | Buy |
42,124
+21,825
| +108% | +$879K | 0.06% | 370 |
|
2024
Q3 | $1.29M | Buy |
20,299
+19,769
| +3,730% | +$1.25M | 0.05% | 413 |
|
2024
Q2 | $28.1K | Buy |
+530
| New | +$28.1K | ﹤0.01% | 1921 |
|
2022
Q4 | – | Sell |
-416
| Closed | -$4K | – | 4862 |
|
2022
Q3 | $4K | Hold |
416
| – | – | ﹤0.01% | 4160 |
|
2022
Q2 | $4K | Hold |
416
| – | – | ﹤0.01% | 3923 |
|
2022
Q1 | $4K | Buy |
416
+400
| +2,500% | +$3.85K | ﹤0.01% | 3923 |
|
2021
Q4 | $1K | Sell |
16
-2,888
| -99% | -$181K | ﹤0.01% | 3090 |
|
2021
Q3 | $32K | Buy |
2,904
+30
| +1% | +$331 | ﹤0.01% | 1728 |
|
2021
Q2 | $15K | Sell |
2,874
-18
| -0.6% | -$94 | ﹤0.01% | 2059 |
|
2021
Q1 | $16K | Buy |
2,892
+381
| +15% | +$2.11K | ﹤0.01% | 1942 |
|
2020
Q4 | $13K | Sell |
2,511
-36
| -1% | -$186 | ﹤0.01% | 1964 |
|
2020
Q3 | $14K | Hold |
2,547
| – | – | ﹤0.01% | 1787 |
|
2020
Q2 | $17K | Hold |
2,547
| – | – | ﹤0.01% | 1621 |
|
2020
Q1 | $12K | Sell |
2,547
-635
| -20% | -$2.99K | ﹤0.01% | 1701 |
|
2019
Q4 | $27K | Buy |
3,182
+53
| +2% | +$450 | ﹤0.01% | 1501 |
|
2019
Q3 | $21K | Buy |
+3,129
| New | +$21K | ﹤0.01% | 1742 |
|
2019
Q1 | $6K | Sell |
600
-2,558
| -81% | -$25.6K | ﹤0.01% | 1811 |
|
2018
Q4 | $24K | Buy |
3,158
+2,558
| +426% | +$19.4K | ﹤0.01% | 2001 |
|
2018
Q3 | $10K | Sell |
600
-4,000
| -87% | -$66.7K | ﹤0.01% | 2834 |
|
2018
Q2 | $44K | Buy |
+4,600
| New | +$44K | ﹤0.01% | 1986 |
|
2016
Q2 | – | Sell |
-600
| Closed | -$6K | – | 4199 |
|
2016
Q1 | $6K | Buy |
+600
| New | +$6K | ﹤0.01% | 1811 |
|